Activation of Antibiotic Production in Bacillus spp. by Cumulative Drug Resistance Mutations.

about

High Levels of Antibiotic Resistance Genes and Their Correlations with Bacterial Community and Mobile Genetic Elements in Pharmaceutical Wastewater Treatment Bioreactors Insights into microbial cryptic gene activation and strain improvement: principle, application and technical aspects.

P2860

Q36050344-79D68BDC-7C03-404D-9ABC-C4E19620FA3D Q38887214-4F6009FE-61B0-4E6D-8C97-81C8C03346F2

P2860

Activation of Antibiotic Production in Bacillus spp. by Cumulative Drug Resistance Mutations.

Item

http://www.wikidata.org/entity/Q36290652

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Activation of Antibiotic Produ ...... ive Drug Resistance Mutations.

@ast

Activation of Antibiotic Produ ...... ive Drug Resistance Mutations.

@en

type

Item

label

Activation of Antibiotic Produ ...... ive Drug Resistance Mutations.

@ast

Activation of Antibiotic Produ ...... ive Drug Resistance Mutations.

@en

prefLabel

Activation of Antibiotic Produ ...... ive Drug Resistance Mutations.

@ast

Activation of Antibiotic Produ ...... ive Drug Resistance Mutations.

@en

P1476

Activation of Antibiotic Produ ...... ive Drug Resistance Mutations.

@en

P2093

Kozo Ochi

http://www.w3.org/2001/XMLSchema#string

Shigeo Tojo

http://www.w3.org/2001/XMLSchema#string

Yukinori Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350

Dramatic activation of antibiotic production in Streptomyces coelicolor by cumulative drug resistance mutations

Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)

Acquisition of certain streptomycin-resistant (str) mutations enhances antibiotic production in bacteria

Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis.

Bacilysocin, a novel phospholipid antibiotic produced by Bacillus subtilis 168

Ribosome engineering and secondary metabolite production.

From microbial differentiation to ribosome engineering.

Activation and products of the cryptic secondary metabolite biosynthetic gene clusters by rifampin resistance (rpoB) mutations in actinomycetes.

The mthA mutation conferring low-level resistance to streptomycin enhances antibiotic production in Bacillus subtilis by increasing the S-adenosylmethionine pool size

P304

7799-7804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01932-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26369962

http://www.w3.org/2001/XMLSchema#string

P932

4649196

http://www.w3.org/2001/XMLSchema#string

Activation of Antibiotic Production in Bacillus spp. by Cumulative Drug Resistance Mutations.

about

P2860

P2860

Activation of Antibiotic Production in Bacillus spp. by Cumulative Drug Resistance Mutations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932